Watch MNOV. Know when insiders buy.
One email the day a filing lands. Free.
MNOV
MEDICINOVA INC
3.32
−0.13 −3.77%
USD · close Sep 18
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
24
FLAG · shorts 24
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $163.4MP/E —DIV YIELD —FCF YIELD -5.58%REV TTM $920KNET INCOME −$10.8MNET CASH $25.4M52W 1.18 – 3.45SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $458K | +240.6% | — | −$2.5M | −$2.3M | — | -0.05 | −$1.9M | $0 | −$1.9M | Aug 13 |
| Q1 2026 · Mar 31 | $187K | — | — | −$2.8M | −$2.6M | — | -0.05 | −$3.5M | $11K | −$3.5M | Aug 13 |
| Q4 2025 · Dec 31derived | $152K | — | — | −$3.1M | −$2.8M | — | -0.05 | −$2M | $0 | −$2M | Mar 10 |
| Q3 2025 · Sep 30 | $123K | — | — | −$3.4M | −$3.1M | — | -0.06 | −$1.7M | $3K | −$1.7M | Nov 12 |
| Q2 2025 · Jun 30 | $135K | — | — | −$3.6M | −$3.3M | — | -0.07 | −$2.3M | $0 | −$2.3M | Aug 13 |
| Q1 2025 · Mar 31 | — | — | — | −$3.2M | −$2.9M | — | -0.06 | −$3.8M | $0 | −$3.8M | Aug 13 |
| Q4 2024 · Dec 31derived | — | — | — | −$3.2M | −$2.8M | — | -0.06 | −$1.9M | −$2 | −$1.9M | Mar 10 |
| Q3 2024 · Sep 30 | — | — | — | −$3.3M | −$2.9M | — | -0.06 | −$2M | $6 | −$2M | Nov 12 |
| Q2 2024 · Jun 30 | — | — | — | −$3M | −$2.6M | — | -0.05 | −$2.8M | — | — | Nov 12 |
| Q1 2024 · Mar 31 | — | — | — | −$3.1M | −$2.8M | — | -0.06 | −$3.9M | — | — | Nov 12 |
| Q4 2023 · Dec 31derived | $0 | — | — | −$2.5M | −$2.1M | — | -0.04 | −$499K | −$22 | −$499K | Feb 19 |
| Q3 2023 · Sep 30 | $1M | — | — | −$1.1M | −$723K | — | -0.01 | −$1.4M | $3K | −$1.4M | Nov 13 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $410K | — | −$13.3M | −$12M | -2928.8% | -0.24 | −$9.8M | $3K | −$9.8M | — | — |
| FY2024 · to Dec 31 | — | — | −$12.7M | −$11M | — | -0.23 | −$10.6M | $895 | −$10.6M | — | — |
| FY2023 · to Dec 31 | $1M | — | −$9.9M | −$8.6M | -857.2% | -0.17 | −$7.4M | $21K | −$7.5M | — | — |
| FY2022 · to Dec 31 | — | — | −$14.6M | −$14.1M | — | -0.29 | −$12.9M | $5K | −$12.9M | — | — |
| FY2021 · to Dec 31 | $4M | — | −$10.2M | −$10.1M | -251.0% | -0.21 | −$9.4M | $29K | −$9.4M | — | — |
| FY2020 · to Dec 31 | — | — | −$14.2M | −$13.9M | — | -0.31 | −$10.8M | $36K | −$10.9M | — | — |
Every number comes from MEDICINOVA INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.